FDA Person
FDAAzeezat M. Lawal
View detailed information about Azeezat M. Lawal, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 15 inspections of 15 companies, 2023–2026.
Inspections (15)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| July 24, 2026 | Airgas USA LLC | Not classified | #1331966 | |
| June 26, 2026 | Boiron Inc. | Not classified | Drug Quality Assurance | #1324326 |
| April 24, 2026 | Fragrance Manufacturing, Inc. dbs FMI | Not classified | Drug Quality Assurance | #1314162 |
| October 24, 2025 | EMS Acquisition Corp | VAI | Drug Quality Assurance | #1280192 |
| August 28, 2025 | Schwabe North America, Inc. | VAI | Drug Quality Assurance | #1271627 |
| May 23, 2025 | Fareva Richmond, Inc. | Not classified | Drug Quality Assurance | #1268369 |
| April 28, 2025 | Eminent Services Corporation | VAI | Drug Quality Assurance | #1268203 |
| February 27, 2025 | C-Care, LLC | Not classified | Drug Quality Assurance | #1259748 |
| December 13, 2024 | Genus Lifesciences Inc. | Not classified | #1256528 | |
| August 29, 2024 | Sharp Clinical Services, LLC | NAI | Drug Quality Assurance | #1250631 |
| June 12, 2024 | Hikma Pharmaceuticals USA Inc. | VAI | Drug Quality Assurance | #1237333 |
| April 9, 2024 | Eisai, Inc. | VAI | New Drug Evaluation | #1237510 |
| February 15, 2024 | ChemPacific Corporation | VAI | Drug Quality Assurance | #1231373 |
| January 18, 2024 | United States Department of Health & Human Services | NAI | Drug Quality Assurance | #1230131 |
| December 15, 2023 | Granules Pharmaceuticals Inc. | VAI | Drug Quality Assurance | #1225087 |
Documents (14)
- 483 · Hikma Pharmaceuticals USA Inc. · June 12, 2024
- EIR · Genus Lifesciences Inc. · December 13, 2024
- 483 · Schwabe North America, Inc. · August 28, 2025
- 483 · ChemPacific Corporation · February 15, 2024
- 483 · EMS Acquisition Corp · October 24, 2025
- 483 · Eminent Services Corporation · April 28, 2025
- 483 · Fareva Richmond, Inc. · May 23, 2025
- 483 · C-Care, LLC · February 27, 2025
- 483 · Genus Lifesciences Inc. · December 13, 2024
- 483 · Granules Pharmaceuticals Inc. · December 15, 2023
- 483 · Eisai, Inc. · April 9, 2024
- 483 · Fragrance Manufacturing, Inc. dbs FMI · April 24, 2026
- 483 · Boiron Inc. · June 26, 2026
- 483 · Airgas USA LLC · July 24, 2026
Frequently inspected with (10)
Johnny D. Nwankwo
3 shared
Yaharn Su
3 shared
Christina K. Theodorou
Consumer Safety Officer
2 shared
Pamela N. Agaba
2 shared
Pushpa S. Jayasekara
Investigator
2 shared
Tekalign Wondimu
Drug Investigator
2 shared
Catherine O. Lamptey
issuing_officer
1 shared
Christian F. Gomez Lugo
1 shared
David A. Oluwo
Pharmacy Intern/Certified Pharmacy Technician
1 shared
Evan Tong
1 shared
Person Information
Name
Azeezat M. Lawal
ID: 6068345c-a8c8-438e-9b59-f7fc35370a59
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.